Stimulant Side Effects
The most common side effects of stimulant medications (methylphenidate, amphetamine salts, dexamfetamine, and lisdexamfetamine) are appetite loss, abdominal pain, headaches, and sleep disturbance, with these effects being generally mild, dose-dependent, and manageable through timing and dose adjustments 1.
Common Side Effects (Occur Frequently)
The following side effects occur most commonly across all stimulant medications:
- Appetite suppression - occurs with all stimulants; manage by giving medication with meals and offering high-calorie snacks in the evening when medication effects wear off 2
- Sleep disturbance/insomnia - particularly problematic with dexamfetamine; address by lowering the last dose of the day or moving it earlier 2, 3
- Abdominal pain - common across all formulations 1
- Headaches - frequently reported 1
- Irritability - more severe with dexamfetamine than methylphenidate; evaluate timing (peak vs. rebound effect) and reduce dose 2, 3
Cardiovascular Effects
Stimulants cause mild increases in heart rate (1-2 beats per minute) and blood pressure (1-4 mm Hg systolic and diastolic) on average 4, 5. However, 5-15% of individuals experience more substantial increases, requiring monitoring of vital signs 4. Before initiating therapy, obtain history of specific cardiac symptoms, Wolf-Parkinson-White syndrome, sudden death in family, hypertrophic cardiomyopathy, and long QT syndrome 1.
Sudden cardiac death in children on stimulants is extremely rare (less than 1/10,000), and evidence is conflicting whether stimulants increase this risk 1.
Growth Effects
Stimulants decrease growth velocity by 1-2 cm from predicted adult height, particularly with higher and more consistently administered doses 1, 4. The MTA study showed:
- Significant decrements in weight acquisition rates compared to non-medication treatment
- Minimal differences in height acquisition during 14-month treatment
- Effects diminished by third year of treatment
- No compensatory rebound growth observed 2, 1
Small weight decrements occur during short-term trials, but prospective follow-up into adult life shows no significant impairment of final height attained 2.
Psychiatric/Emotional Side Effects
- Mood disturbances - can occur, particularly dysphoria when medication wears off 2
- Hallucinations and psychotic symptoms - uncommon but significant adverse effect 1
- Emotional lability - more problematic with amphetamines than methylphenidate 6
- Sadness, crying, anxiousness, nightmares - significantly more severe with dexamfetamine than methylphenidate 3
- Preschool-aged children may experience increased mood lability and dysphoria 1
Medication-Specific Differences
Dexamfetamine causes more severe side effects than methylphenidate, specifically:
- More severe insomnia 3
- Greater appetite suppression 3
- More irritability, proneness to crying, anxiousness, sadness/unhappiness, and nightmares 3
Lisdexamfetamine (prodrug of dexamfetamine) has similar side effect profile: decreased appetite, headache, weight reduction, insomnia, and irritability 7, 8. Recent real-world data suggests it may cause less insomnia and end-of-dose crash compared to other amphetamine formulations 9.
Rare but Serious Side Effects
With an estimated 3 million children taking stimulants daily in the US, serious side effects occur at rates less than 1/10,000 2. These include:
- Seizures (particularly with high-dose methylphenidate in adults) 2
- Severe psychosis or hallucinosis 2
- Cognitive impairment or perseverative behaviors (usually responds to dose decrease) 2
Important Clinical Pitfalls
Many symptoms commonly attributed to stimulants are actually pre-existing ADHD characteristics that improve with treatment 3. Parents reported significantly more "side effects" at baseline (mean 8.19 symptoms) than during methylphenidate treatment (mean 7.19 symptoms) 3.
Motor tics: Controlled studies have not found that methylphenidate worsens motor tics in Tourette's syndrome or increases tics in ADHD children without Tourette's 2. However, amphetamines may worsen tic severity more than methylphenidate 2.
Abuse and Dependence Potential
All stimulants are Schedule II controlled substances with high potential for abuse and misuse 10. Misuse and abuse can cause:
- Increased heart rate, respiratory rate, blood pressure
- Sweating, dilated pupils, hyperactivity, restlessness
- Anxiety, psychosis, hostility, aggression
- Suicidal or homicidal ideation
- Risk of overdose and death, particularly with unapproved administration methods 10
Physical dependence can develop, with withdrawal symptoms including dysphoric mood, depression, fatigue, vivid unpleasant dreams, insomnia or hypersomnia, increased appetite, and psychomotor changes 10.
Management Strategies
For appetite loss: Give stimulants with meals and high-calorie drink/snack late evening when effects wear off 2
For insomnia: Distinguish whether due to medication side effect or oppositional behavior; lower last dose or move earlier in day; implement bedtime ritual 2
For sadness: Reevaluate diagnosis, reduce dose, switch to sustained-release products as immediate-release peak may cause more depressive effects 2
For behavioral rebound: Overlap dosing pattern, switch to longer-acting stimulants, combine immediate-release with sustained-release 2
For irritability: Evaluate timing (peak vs. rebound); reduce dose 2